IN8BIO, INC. (INAB)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-05-27FAIRBAIRN EMILYdirectorG724,6370$0
2025-12-22Rochlin KateofficerA7,2471.38$10,001
2025-12-22McCall PatrickofficerA7,2471.38$10,001
2025-12-22Ho William Tai-WeidirectorA36,2321.38$50,000
2025-12-22Roemer Alan S.directorA36,2321.38$50,000
2025-12-22Brandt Peter C.directorA72,4641.38$100,000
2025-12-22FAIRBAIRN EMILYdirectorA724,6371.38$999,999
2025-04-30Rochlin KateofficerM12,2950.18$2,213
2025-04-30McCall PatrickofficerM15,0000.18$2,700
2025-04-30Roemer Alan S.directorM11,0000.18$1,980
2025-04-30Roemer Alan S.directorM102,4590.18$18,443
2025-04-30Brandt Peter C.directorM81,9670.18$14,754
2025-04-30Brandt Peter C.directorM81,9670.18$14,754
2024-10-04Rochlin KateofficerA25,316
2024-10-04McCall PatrickofficerA25,316
2024-10-04Roemer Alan S.directorA126,582
2024-10-04Brandt Peter C.directorA253,164
2024-10-04Ho William Tai-WeidirectorA126,582

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings